Dale Broadrick, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 2,500 shares at $5.66 ($14K) on 2022-04-06, disclosed to the SEC on 2022-04-08.
Open-market purchase of $14k BRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| BRTX | BUY | 2024-02-09 | $325K | — | Filing → |
| BRTX | SELL | 2023-12-05 | $470 | — | Filing → |
| BRTX | SELL | 2023-12-01 | $525 | — | Filing → |